Answers are grounded in this paper and cite their sources.
Polymorphisms in the CYP3A5 gene explain 40-50% of the variability in tacrolimus dose requirement, at least in Caucasians.The residual variability in tacrolimus clearance is at yet unexplained."
No takes yet. Share an insight, caveat, or question.
Andrews et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: